Bing-Mae Chen Selected Research

tetra-n-butyl ammonium salt p-hydroxyaniline mustard glucuronide

5/2006

Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing-Mae Chen Research Topics

Disease

14	Neoplasms (Cancer) 02/2024 - 01/2003
3	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2003
2	Hypersensitivity (Allergy) 01/2023 - 10/2021
2	Anemia 02/2022 - 12/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2015
2	Melanoma (Melanoma, Malignant) 05/2004 - 01/2003
1	COVID-19 01/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Hypothermia 01/2023
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2023
1	Diarrhea 01/2021
1	Immunoglobulin G4-Related Disease 01/2020
1	Triple Negative Breast Neoplasms 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Breast Ductal Carcinoma 06/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 06/2015
1	Adenocarcinoma 06/2015
1	Infections 06/2010
1	Lung Neoplasms (Lung Cancer) 07/2003
1	Carcinoma (Carcinomatosis) 07/2003
1	Experimental Melanoma 01/2003
1	Lewis Lung Carcinoma 01/2003

Drug/Important Bio-Agent (IBA)

5	AntigensIBA 02/2024 - 07/2003
5	ProdrugsIBA 02/2024 - 05/2004
4	AntibodiesIBA 01/2023 - 01/2003
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2003
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2024 - 01/2015
3	Liposomes (Liposome)IBA 01/2023 - 06/2015
3	Immunoglobulin M (IgM)IBA 01/2023 - 01/2003
3	GlucuronidaseIBA 01/2021 - 09/2009
3	liposomal doxorubicin (Doxil)FDA Link 01/2018 - 12/2014
3	GlucuronidesIBA 05/2011 - 05/2006
2	Platelet Activating FactorIBA 01/2023 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2015
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2023 - 01/2016
2	LipidsIBA 01/2023 - 01/2016
2	continuous erythropoietin receptor activator FDA Link 02/2022 - 12/2019
2	Peptides (Polypeptides)IBA 01/2016 - 06/2010
2	EnzymesIBA 05/2011 - 05/2006
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 05/2006 - 05/2004
2	Monoclonal AntibodiesIBA 07/2003 - 01/2003
1	VaccinesIBA 01/2023
1	1-dodecylpyridoxal (PLD)IBA 01/2023
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Melitten (Melittin)IBA 10/2021
1	CV 6209IBA 10/2021
1	Methylprednisolone Hemisuccinate (A-MethaPred)FDA LinkGeneric 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	LigandsIBA 01/2016
1	EpitopesIBA 01/2016
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2016
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2016
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2016
1	Topoisomerase I InhibitorsIBA 01/2015
1	Carboxylesterase (Hydrolase S)IBA 01/2015
1	monomethoxypolyethylene glycol (MPEG)IBA 12/2014
1	Bispecific AntibodiesIBA 12/2014
1	Phenolphthalein (Modane)IBA 09/2009
1	CytokinesIBA 05/2006
1	HaptensIBA 05/2006
1	Single-Chain AntibodiesIBA 05/2006
1	Aniline MustardIBA 05/2006
1	1- myristoyl- 2- (12- ((5- dimethylamino- 1- naphthalenesulfonyl)amino)dodecanoyl)- sn- glycero- 3- phosphocholineIBA 05/2006
1	tetra-n-butyl ammonium salt p-hydroxyaniline mustard glucuronideIBA 05/2006
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2003
1	matrigelIBA 01/2003
1	Neoplasm AntibodiesIBA 01/2003

Therapy/Procedure

8	Therapeutics 02/2024 - 07/2003
2	Intravenous Administration 02/2024 - 05/2006
1	Aftercare (After-Treatment) 01/2018
1	Immunotherapy 01/2016
1	Drug Therapy (Chemotherapy) 05/2011